Estrogen and progesterone receptor mrna levels in primary breast cancer association with patient survival and other clinical and tumor features (1994)
- Authors:
- USP affiliated authors: BRENTANI, MARIA MITZI - FM ; NAGAI, MARIA APARECIDA - FM
- Unidade: FM
- DOI: 10.1002/ijc.2910590310
- Assunto: ONCOLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: International Journal of Cancer
- Volume/Número/Paginação/Ano: v.59, p.351-6, 1994
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
NAGAI, Maria Aparecida; MARQUES, L A; YAMAMOTO, L; FUJIYAMA, C T; BRENTANI, Maria Mitzi. Estrogen and progesterone receptor mrna levels in primary breast cancer association with patient survival and other clinical and tumor features. International Journal of Cancer, New York, v. 59, p. 351-6, 1994. DOI: 10.1002/ijc.2910590310. -
APA
Nagai, M. A., Marques, L. A., Yamamoto, L., Fujiyama, C. T., & Brentani, M. M. (1994). Estrogen and progesterone receptor mrna levels in primary breast cancer association with patient survival and other clinical and tumor features. International Journal of Cancer, 59, 351-6. doi:10.1002/ijc.2910590310 -
NLM
Nagai MA, Marques LA, Yamamoto L, Fujiyama CT, Brentani MM. Estrogen and progesterone receptor mrna levels in primary breast cancer association with patient survival and other clinical and tumor features. International Journal of Cancer. 1994 ;59 351-6. -
Vancouver
Nagai MA, Marques LA, Yamamoto L, Fujiyama CT, Brentani MM. Estrogen and progesterone receptor mrna levels in primary breast cancer association with patient survival and other clinical and tumor features. International Journal of Cancer. 1994 ;59 351-6. - A expressão do protooncogene C-MYC na próstata humana é modulada pela ação de androgênios
- Overexpression of the c-myc proto-oncogene in breast cancer
- Gene expression profile of estrogen receptor negative breast cancer cells transfected with cDNA for estrogen receptor
- Tumor-associated genes differentially expressed in breast tumors regarding the presence or absence of estrogen and progesterone receptors
- Genetic alteration of the c-erb-8-2 protooncogene in a group of primary human breast carcinomas
- Alteration of the c-erbb-2 protooncogene in a group of primary human carcinomas
- Over-expression of the oncogenes c-myc and c-erb b-2 in breast carcinoma
- Overexpression and relaxation of insulin-like growth factor 2 (IGF2) gene imprinting in fibroadenomas of the breast
- PAWR/PAR-4 expression is modulated by 17 beta estradiol and IGF 1 breast cancer cells
- Genetic alterations in juvenile nasopharyngeal angiofibromas
Informações sobre o DOI: 10.1002/ijc.2910590310 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
